Acetaminophen Relieves Inflammatory Pain Through CB1 Cannabinoid Receptors in the Rostral Ventromedial Medulla

Acetaminophen Relieves Inflammatory Pain Through CB1 Cannabinoid Receptors in the Rostral Ventromedial Medulla

322 • The Journal of Neuroscience, January 10, 2018 • 38(2):322–334 Systems/Circuits Acetaminophen Relieves Inflammatory Pain through CB1 Cannabinoid Receptors in the Rostral Ventromedial Medulla X Pascal P. Klinger-Gratz,1* William T. Ralvenius,1* Elena Neumann,1 Ako Kato,1 XRita Nyilas,2 XZsolt Lele,2 X Istva´n Katona,2 and XHanns Ulrich Zeilhofer1,3 1Institute of Pharmacology and Toxicology, University of Zurich, CH-8057 Zurich, Switzerland, 2Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Hungary, and 3Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zurich, CH-8093 Zu¨rich, Switzerland Acetaminophen (paracetamol) is a widely used analgesic and antipyretic drug with only incompletely understood mechanisms of action. Previous work, using models of acute nociceptive pain, indicated that analgesia by acetaminophen involves an indirect activation of CB1 receptors by the acetaminophen metabolite and endocannabinoid reuptake inhibitor AM 404. However, the contribution of the canna- binoid system to antihyperalgesia against inflammatory pain, the main indication of acetaminophen, and the precise site of the relevant CB1 receptors have remained elusive. Here, we analyzed acetaminophen analgesia in mice of either sex with inflammatory pain and found that acetaminophen exerted a dose-dependent antihyperalgesic action, which was mimicked by intrathecally injected AM 404. Both ؊/؊ compounds lost their antihyperalgesic activity in CB1 mice, confirming the involvement of the cannabinoid system. Consistent with a mechanism downstream of proinflammatory prostaglandin formation, acetaminophen also reversed hyperalgesia induced by intrathe- cal prostaglandin E2. To distinguish between a peripheral/spinal and a supraspinal action, we administered acetaminophen and AM 404 ؊/؊ to hoxB8-CB1 mice, which lack CB1 receptors from the peripheral nervous system and the spinal cord. These mice exhibited unchanged antihyperalgesia indicating a supraspinal site of action. Accordingly, local injection of the CB1 receptor antagonist rimonabant into the rostral ventromedial medulla blocked acetaminophen-induced antihyperalgesia, while local rostral ventromedial medulla injection of ؊/؊ AM 404 reduced hyperalgesia in wild-type mice but not in CB1 mice. Our results indicate that the cannabinoid system contributes not onlytoacetaminophenanalgesiaagainstacutepainbutalsoagainstinflammatorypain,andsuggestthattherelevantCB1 receptorsreside in the rostral ventromedial medulla. Key words: acetaminophen; AM 404; analgesia; inflammation; N-arachidonoylphenolamin; paracetamol Significance Statement Acetaminophen is a widely used analgesic drug with multiple but only incompletely understood mechanisms of action, including afacilitationofendogenouscannabinoidsignalingviaoneofitsmetabolites.Ourpresentdataindicatethatenhancedcannabinoid signaling is also responsible for the analgesic effects of acetaminophen against inflammatory pain. Local injections of the acet- aminophen metabolite AM 404 and of cannabinoid receptor antagonists as well as data from tissue-specific CB1 receptor-deficient mice suggest the rostral ventromedial medulla as an important site of the cannabinoid-mediated analgesia by acetaminophen. Introduction analgesic action. These include the inhibition of cyclooxygenases In the past decades, several potential molecular mechanisms have (COXs) (Flower and Vane, 1972; Hanel and Lands, 1982; Gra- been proposed that may explain how acetaminophen exerts its ham and Scott, 2005), the activation of spinal serotonergic de- scending projections (Tjølsen et al., 1991; Pini et al., 1996), an involvement of the brain opioid system (Tjølsen et al., 1991; Her- Received July 9, 2017; revised Oct. 27, 2017; accepted Nov. 14, 2017. rero and Headley, 1996; Pini et al., 1996; Sandrini et al., 2001), Author contributions: W.T.R., I.K., and H.U.Z. designed research; P.P.K.-G., W.T.R., E.N., A.K., R.N., Z.L., and I.K. performed research; P.P.K.-G., W.T.R., E.N., A.K., R.N., Z.L., I.K., and H.U.Z. analyzed data; I.K. and H.U.Z. wrote the inhibition of nitric oxide generation (Bjo¨rkman et al., 1994; paper. Bujalska, 2004), and activation of spinal TRPA1 channels by the ThisworkwassupportedinpartbyFederalGovernmentofSwitzerland,SwissContributionGrantSH7/2/18toI.K. and H.U.Z., and Hungarian Academy of Sciences Momentum Program LP-54/2013 to I.K., E.N. was supported by a Deutsche Forschungsgemeinschaft scholarship. We thank Drs. Beat Lutz and Giovanni Marsicano for providing *P.P.K.-G. and W.T.R. contributed equally to this study. fl/fl CB1 mice; Dr. Masahiko Watanabe for the CB1 receptor antibody; Se´bastien Druart, Andreas Pospischil, and Rose- Correspondence should be addressed to Dr. Hanns Ulrich Zeilhofer, Institute of Pharmacology and Toxicology, line Weilenmann for the analyses of biomarkers of liver damage; and Isabelle Kellenberger, Bala´zs Pinte´r, Erika University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. E-mail: [email protected]. Tischler, and Louis Scheurer for technical assistance. DOI:10.1523/JNEUROSCI.1945-17.2017 The authors declare no competing financial interests. Copyright © 2018 the authors 0270-6474/18/380322-13$15.00/0 Klinger-Gratz, Ralvenius et al. • RVM Cannabinoid Signaling in Acetaminophen Analgesia J. Neurosci., January 10, 2018 • 38(2):322–334 • 323 acetaminophen metabolites N-acetyl-p-benzoquinoneimine date to the test confinement for at least 1 h before starting behavioral (NAPQI) and p-benzoquinone (Andersson et al., 2011). In addi- experiments. Mechanical sensitivity was measured using electronically tion, the generation of N-arachidonoylphenolamin (AM 404) controlled von Frey filaments (IITC). At least three measurements were from acetaminophen through deacetylation to p-aminophenol made for each time point. The experimenter was blind to the genotype or and the subsequent conjugation with arachidonic acid by CNS to the type of treatment (vehicle or drug) in all experiments. Permission for animal experiments was obtained from the Veterina¨ramt des Kantons fatty amide hydrolase (FAAH) (Ho¨gestatt et al., 2005) has drawn Zu¨rich (licenses 92/2007, 126/2012, and 031/2016). the attention to a possible involvement of the endocannabinoid Inflammatory hyperalgesia was induced using the yeast extract zymo- system. AM 404 increases tissue concentrations of the endocannabi- sanA(Meller and Gebhart, 1997). Zymosan A (Fluka) was suspended in noid arachidonoyl ethanolamide, also known as anandamide, 0.9% NaCl and injected subcutaneously (0.06 mg/20 ␮l) into the plantar through an inhibition of anandamide reuptake into neurons and side of the left hindpaw 24 h before the administration of acetaminophen astrocytes (Beltramo et al., 1997; Fegley et al., 2004). After spinal or or AM 404. Spinal PGE2-induced hyperalgesia was evoked through in- ␮ systemic application, AM 404 exerts analgesic activity against acute trathecal injection of prostaglandin E2 (PGE2; Sigma; 0.4 nmol/4 l, pain, evoked by noxious chemical stimuli, as well as against inflam- dissolved in 1% ethanol and 99% aCSF). Intrathecal injections were matory and neuropathic pain (Gu¨hring et al., 2002; La Rana et al., made 1 h before application of acetaminophen (Reinold et al., 2005). 2006). In line with an important contribution of the endocannabi- Drug administration, intrathecal and intra-RVM injections. Acetamin- ophen (Sigma) was dissolved in 0.9% NaCl. The acetaminophen- noid system, acetaminophen-mediated antinociception was lost in ␮ Ϫ/Ϫ containing solution or vehicle (0.9% NaCl, 400 l) was given orally CB1 receptor-deficient (CB1 ) mice (Mallet et al., 2008) as well as Ϫ/Ϫ through stainless-steel tubes (Delvo). Rimonabant (SR141716A; Tocris in mice lacking FAAH (FAAH mice) (Mallet et al., 2010). Ac- Bioscience) (Rinaldi-Carmona et al., 1994) was dissolved in a mixture of cordingly, acetaminophen-induced analgesia was also reduced by 43% (v/v) DMSO, 43% aCSF, and 14% ethanol. Injection volumes were ␮ the FAAH inhibitor URB 597 (Mallet et al., 2008) and by the CB1 5 and 4 l for AM 404 (Tocris Bioscience) and PGE2, respectively. AM receptor antagonists AM 251 and rimonabant (Ottani et al., 2006; 404 (Tocris Bioscience) was dissolved in 40% DMSO and 60% 0.9% Dani et al., 2007; Mallet et al., 2008). NaCl. Intrathecal injections were performed under isoflurane anesthesia The studies discussed above support a contribution of the at the level of the lumbar spine using a Hamilton syringe (Ahmadi et al., endocannabinoid system to acetaminophen-mediated analgesia. 2001). A small amount of black ink (1% v/v) was added to permit post hoc However, most of these studies (Ottani et al., 2006; Mallet et al., verification of proper intrathecal injections. Injections into the RVM 2008, 2010) tested acetaminophen in models of acute nociceptive were performed with stainless-steel cannulas. Fully anesthetized mice were placed in a Kopf stereotaxic frame and implanted with a cannula pain (i.e., pain evoked by acute noxious thermal, mechanical, or using the following coordinates, which were calibrated to the cranial chemical stimuli applied to naive animals in the absence of noci- ϭϪ ϭ ϭ bregma points: x 5.7; y 0; zcranium 4.2. The cannula was fixed ceptive sensitization by inflammation or neuropathy). These with dental cement, and the cement was secured at the skull with 2 or 3 acute pain models only poorly reflect the clinical indications for screws. The fixed cannula was used to insert a 30 G needle attached to a acetaminophen,

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    13 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us